SOX10

SRY (sex determining region Y)-box 10
Identifiers
Symbols	SOX10 ; DOM; MGC15649; WS4
External IDs	Template:OMIM5 Template:MGI HomoloGene: 5055
Gene ontology Molecular function Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO Cellular component Template:GNF GO Biological process Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO Template:GNF GO
RNA expression pattern
File:PBB GE SOX10 209842 at tn.png
File:PBB GE SOX10 209843 s at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species	Human	Mouse
Entrez	n/a	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	n/a	n/a

SRY (sex determining region Y)-box 10, also known as SOX10, is a human gene.

This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional activator after forming a protein complex with other proteins. This protein acts as a nucleocytoplasmic shuttle protein and is important for neural crest and peripheral nervous system development. Mutations in this gene are associated with Waardenburg-Shah and Waardenburg-Hirschsprung disease.

See also

• SOX genes

Further reading

• Jacobs JM, Wilson J (1992). "An unusual demyelinating neuropathy in a patient with Waardenburg's syndrome". Acta Neuropathol. 83 (6): 670–4. PMID 1636383.
• Southard-Smith EM, Kos L, Pavan WJ (1998). "Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model". Nat. Genet. 18 (1): 60–4. doi:10.1038/ng0198-60. PMID 9425902.CS1 maint: Multiple names: authors list (link)
• Pingault V, Bondurand N, Kuhlbrodt K; et al. (1998). "SOX10 mutations in patients with Waardenburg-Hirschsprung disease". Nat. Genet. 18 (2): 171–3. doi:10.1038/ng0298-171. PMID 9462749.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Kuhlbrodt K, Schmidt C, Sock E; et al. (1998). "Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients". J. Biol. Chem. 273 (36): 23033–8. PMID 9722528.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Pusch C, Hustert E, Pfeifer D; et al. (1998). "The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor". Hum. Genet. 103 (2): 115–23. PMID 9760192.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Bondurand N, Kuhlbrodt K, Pingault V; et al. (2000). "A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies". Hum. Mol. Genet. 8 (9): 1785–9. PMID 10441344.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Inoue K, Tanabe Y, Lupski JR (1999). "Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation". Ann. Neurol. 46 (3): 313–8. PMID 10482261.CS1 maint: Multiple names: authors list (link)
• Dunham I, Shimizu N, Roe BA; et al. (1999). "The DNA sequence of human chromosome 22". Nature. 402 (6761): 489–95. doi:10.1038/990031. PMID 10591208.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Touraine RL, Attié-Bitach T, Manceau E; et al. (2000). "Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain". Am. J. Hum. Genet. 66 (5): 1496–503. PMID 10762540.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Bondurand N, Pingault V, Goerich DE; et al. (2000). "Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome". Hum. Mol. Genet. 9 (13): 1907–17. PMID 10942418.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Smit DJ, Smith AG, Parsons PG; et al. (2000). "Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors". Eur. J. Biochem. 267 (21): 6413–22. PMID 11029584.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Sham MH, Lui VC, Chen BL; et al. (2002). "Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome". J. Med. Genet. 38 (9): E30. PMID 11546831.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Rehberg S, Lischka P, Glaser G; et al. (2002). "Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation". Mol. Cell. Biol. 22 (16): 5826–34. PMID 12138193.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Pingault V, Girard M, Bondurand N; et al. (2002). "SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism". Hum. Genet. 111 (2): 198–206. doi:10.1007/s00439-002-0765-8. PMID 12189494.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Lang D, Epstein JA (2004). "Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer". Hum. Mol. Genet. 12 (8): 937–45. PMID 12668617.
• Shimotake T, Tomiyama H, Aoi S, Iwai N (2003). "Discrepancy between macroscopic and microscopic transitional zones in Hirschsprung's disease with reference to the type of RET/GDNF/SOX10 gene mutation". J. Pediatr. Surg. 38 (5): 698–701. doi:10.1016/jpsu.2003.50186. PMID 12720173.CS1 maint: Multiple names: authors list (link)
• Huber WE, Price ER, Widlund HR; et al. (2003). "A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes". J. Biol. Chem. 278 (46): 45224–30. doi:10.1074/jbc.M309036200. PMID 12944398.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Chan KK, Wong CK, Lui VC; et al. (2004). "Analysis of SOX10 mutations identified in Waardenburg-Hirschsprung patients: Differential effects on target gene regulation". J. Cell. Biochem. 90 (3): 573–85. doi:10.1002/jcb.10656. PMID 14523991.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Inoue K, Khajavi M, Ohyama T; et al. (2004). "Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations". Nat. Genet. 36 (4): 361–9. doi:10.1038/ng1322. PMID 15004559.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)

External links

• SOX10+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)

This article incorporates text from the United States National Library of Medicine, which is in the public domain.